Close
Close

Coxsackie A16 virus (CA16) Inactivated Virus (CAT#: VLP-049YF)

Datasheet
Coxsackie A16 virus stock is produced by cell culture and formulated with purified, intact viral particles. The virus particles have been chemically modified to render them non-infectious and refrigerator stable. The inactivation was verified in a standard microbiological growth protocol. CA16 stock can be used in the development of CA16 diagnostics and in vaccine development and R&D.

Product Specifications

  • Expression Systems
  • Cell culture
  • Purity
  • >90%
  • Form
  • Liquid
  • Alternative Names
  • Coxsackie A16 virus; CA16; Coxsackie A16 virus antigen; CA16 antigen
  • Storage
  • Store at -80°C long term. Avoid repeated freeze/thaw cycles.

Virus Background

  • Virus Family
  • Picornaviridae
  • Virus Species
  • Enterovirus A
  • Virus Overview
  • Coxsackie A virus is a subgroup of enterovirus A, which are small, non-enveloped, positive-sense, single-stranded RNA viruses. It's protective, icosahedral capsid has an external portion that contains sixty copies of viral proteins (VP1,-2,-3) and an internal portion surrounding the RNA genome containing sixty copies of VP4 viral proteins. This capsid mediates cell entry and illicit the humoral immune responses. Enteroviruses have a depression encircling each fivefold axis (canyon), which is their binding site for immunoglobulin-like receptors. This binding can trigger viral expansion and release of its genome.
  • Virus Structure
  • Non-enveloped, positive-sense, single-stranded RNA virus
  • Related Disease
  • Hand, foot and mouth disease (HFMD)

Customer reviews and Q&As    

Related Products
Online Inquiry
CONTACT US
USA:
Europe:
Germany:
Call us at:
USA:
UK:
Germany:
Fax:
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2024 Creative Biolabs. | Contact Us